Method for the treatment of bone disorders

Details for Australian Patent Application No. 2002360619 (hide)

Owner The Procter & Gamble Company

Inventors Schofield, Pamela Jean; Chines, Arkadi Aaron; Burgio, David Ernest; Van den Berg,Henry

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002360619

PCT Number PCT/US02/40234

PCT Pub. Number WO2003/055496

Priority 60/344,875 21.12.01 US

Filing date 16 December 2002

Wipo publication date 15 July 2003

Acceptance publication date 5 October 2006

International Classifications

A61K 31/663 (2006.01)

A61K 31/66 (2006.01) - Phosphorus compounds

A61K 31/675 (2006.01) - having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 60/344,875 21.12.01 US

4 September 2003 Application Open to Public Inspection

  Published as AU-B-2002360619

5 October 2006 Application Accepted

  Published as AU-B-2002360619

8 February 2007 Standard Patent Sealed

18 February 2010 Assignment Registered

  The Procter & Gamble Company The patent has been assigned to Warner Chilcott Company, LLC

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002360620-THERAPEUTIC COMPOUNDS FOR TREATING DYSLIPIDEMIC CONDITIONS

2002360618-Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands